Vanguard Group’s Sagimet Biosciences SGMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.79M | Hold |
1,153,856
| – | – | ﹤0.01% | 2971 |
|
|
2025
Q1 | $3.76M | Buy |
1,153,856
+22,729
| +2% | +$74.1K | ﹤0.01% | 3277 |
|
|
2024
Q4 | $5.09M | Buy |
1,131,127
+83,587
| +8% | +$376K | ﹤0.01% | 3264 |
|
|
2024
Q3 | $2.9M | Sell |
1,047,540
-26,598
| -2% | -$73.7K | ﹤0.01% | 3446 |
|
|
2024
Q2 | $3.67M | Sell |
1,074,138
-65,269
| -6% | -$223K | ﹤0.01% | 3381 |
|
|
2024
Q1 | $6.18M | Buy |
1,139,407
+894,319
| +365% | +$4.85M | ﹤0.01% | 3213 |
|
|
2023
Q4 | $1.33M | Sell |
245,088
-930
| -0.4% | -$5.04K | ﹤0.01% | 3740 |
|
|
2023
Q3 | $2.16M | Buy |
+246,018
| New | +$2.16M | ﹤0.01% | 3555 |
|